STTROpen

MEDICAL SWARM ROBOTICS FOR EXTRACTION AND LIFE-SAVING INTERVENTIONS

Solicitation ID26.TZ
Agency
DOD
DARPA
Deadline
Jun 3, 2026
21 days left
Posted Date
Apr 13, 2026
Classification
STTR
Phase: BOTH

STTR Opportunity Analysis

DARPA, within the Department of Defense, is seeking STTR proposals for DPA26TZ01-NV001 to develop small robotic swarms that can autonomously provide battlefield medical assistance and life-saving interventions. The work calls for self-deploying, wound-assessing, swarm-capable robots that can support casualty movement, hemorrhage control, fracture stabilization, or medication delivery in hard-to-reach environments. Proposals must demonstrate at least two capabilities, including one from extraction and one from treatment, with Phase I focused on feasibility of modular swarm architecture, sensing, mobility, and interlocking or shape-changing features, and Phase II requiring a ruggedized prototype tested in operationally relevant settings along with commercialization and FDA planning. The opportunity opened on May 6, 2026, and applications are due June 3, 2026 at 4:00 PM UTC.

SBIR Documents

1 Files
1776211345558.pdf
PDF95 KBMay 11, 2026
AI Summary
The DPA26TZ01-NV001 program seeks to develop small robotic swarms for autonomous battlefield medical assistance. This initiative addresses critical needs in future Large Scale Combat Operations (LSCO), where massive casualties and delayed evacuations are anticipated, leading to preventable deaths from hemorrhage. The objective is to create self-deploying, wound-assessing, swarm-capable robots that can perform life-saving interventions (LSIs) like casualty movement, hemorrhage control, fracture stabilization, and medication delivery in difficult-to-reach areas. Proposals should demonstrate at least two capabilities, one from 'Extraction' (casualty movement or limb stabilization) and one from 'Treatment' (hemorrhage control or medication delivery). Phase I focuses on demonstrating the feasibility of modular swarm architecture, sensing, mobility, and design for treatment and interlocking units. Phase II involves developing a ruggedized prototype to perform the selected interventions on high-fidelity phantoms in operationally relevant environments, alongside commercialization, transition planning, and FDA acceptance plans. Phase III encourages dual-use applications in disaster response and military casualty care.

Related SBIR/STTR Opportunities

Opportunity Snapshot

Source SystemOfficial Link
Program Type
STTR - BOTH
Agency
DOD / DARPA

Key Dates

Release DateApr 13, 2026
Open DateMay 6, 2026
Application DueJun 3, 2026
Close DateJun 3, 2026